|
DSpace at RU >
Browsing by Author Gore, M.E.
Showing results 1 to 4 of 4
| Full Text | Issue Date | Title | Author(s) | | 2010 | Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial. | Gore, M.E.; Griffin, C.L.; Hancock, B.; Patel, P.M.; Pyle, L., et al |
| 2010 | Common variants at 19p13 are associated with susceptibility to ovarian cancer. | Bolton, K.L.; Tyrer, J.P.; Song, H.; Ramus, S.J.; Notaridou, M., et al |
| 2010 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. | Goode, E.L.; Chenevix-Trench, G.; Song, H.; Ramus, S.J.; Notaridou, M., et al |
| 2008 | Establishing the role of cytokine therapy in advanced renal cell carcinoma. | Gore, M.E.; Mulder, P.H.M. de |
Showing results 1 to 4 of 4
|